Dr. Gerd Michel Email & Phone Number

Dr. Gerd Michel obtained his PhD from the University of Heidelberg, Germany, where he was head of the Receptor Research Laboratory at the Institute of Pathophysiology, Dept. of Internal Medicine. After two years in the private laboratory sector he joined Abbott Laboratories as a founding member of their European Research unit which increased from an initial 3 employees to an operation of >600 at the time he left Abbott. He spent more than 18 years with Abbott Diagnostics rising to the post of Medical and Scientific Director for Europe, Middle East & Africa. Among various management functions he also had responsibility for OEM product development and assessment of new technologies. Among his numerous product successes with high commercial impact were HCV, HIV and cardiac Troponin I tests that became state of the art diagnostics worldwide. He was heading immunodiagnostics at the Foundation of New Innovative Diagnostics (FIND) in Geneva, Switzerland, for more than 7 years, mainly funded by the Bill and Melinda Gates Foundation. Subsequently he became Chief Scientific Officer and Vice President of Vela Diagnostics in Singapore, focusing on molecular and personalized diagnostics. His company developed into a major player in Next Generation Sequencing, generating numerous products such as the current market leading assay for HIV drug resistance testing (FDA approved 2020).In 2020 he founded GMLifeSciences Consulting based in Heidelberg, Germany.He received several industry and academic awards for his work, has (co-) authored >180 peer-reviewed publications and is an internationally requested reviewer and speaker. He is also an inventor on a number of patents. He holds fellowships from the University of Aarhus, Denmark, and the German Cancer Research Centre (Dept. Harald zur Hausen; Nobel Prize 2008). He has held a number of advisory posts, e.g. at WHO and the OECD. He served as a member of the German National Blood Advisory Board of the Ministry of Health at the Robert Koch Institute and is currently a member of several international Research Funding Committees, e.g. at the Wellcome Trust, London, and the Global Health Innovation Fund, Tokyo, respectively. In addition to his scientific career he completed business education at Northwestern University in Chicago and is an alumnus of the Institute of Management Development (IMD), Lausanne, Switzerland, two of the top rated international business schools.